Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FXNC4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,847
Award facts
- Contract value 100% obligated
- $12,846.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,846.80 delivery order (Contract No. 4570092023) to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and a completion deadline of November 25, 2025. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and other government healthcare systems. As a prime contractor under the DLA's pharmaceutical supply framework, the company maintains a comprehensive portfolio delivering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This particular delivery order for Repatha, a PCSK9 inhibitor used in cardiovascular disease management, reflects the company's role in supporting military and veteran healthcare needs through competitively awarded contracts with firm fixed pricing.
Quick answers
Who was awarded contract SPE2DR26FXNC4?
SPE2DR26FXNC4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FXNC4 worth?
The government has obligated $12,847 on SPE2DR26FXNC4.
Is contract SPE2DR26FXNC4 an order under another contract?
Yes. SPE2DR26FXNC4 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXNC4 competed?
The extent of competition for SPE2DR26FXNC4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award